What is their latest estimate of the national annual cost of pathology testing carried outin National Health Service primary care trusts.

What is their latest estimate of the national annual cost of pathology testing carried outin National Health Service primary care trusts.

What support will be provided by (a) theFood Standards Agency, and (b) the European Food Safety Authority for small and medium-sized enterprises under the European Union nutrition and health claims made on foods regulation.

What support will be provided by (a) theFood Standards Agency, and (b) the European Food Safety Authority for small and medium-sized enterprises under the European Union nutrition and health claims made on foods regulation.

What definition has been agreed between European Union member states for generally accepted scientific evidence under the European Union nutrition and health claims made on foods regulation; and what guidance will be available to food manufacturers from the European Food Safety Authority for submissions to the Community register of health...

What definition has been agreed between European Union member states for generally accepted scientific evidence under the European Union nutrition and health claims made on foods regulation; and what guidance will be available to food manufacturers from the European Food Safety Authority for submissions to the Community register of health...

Whether they provide information to overweight and obese National Health Service patients on the use of proven effective commercial diets; and

Whether they provide information to overweight and obese National Health Service patients on the use of proven effective commercial diets; and

Whether meal replacements for weight control, as regulated in the Foods Intended for Use in Energy Restricted Diets for Weight Reduction Regulations 1997 (SI 1997/2182), will be included in the obesity guidance currently under review by the National Institute for Health and Clinical Excellence; and

Whether meal replacements for weight control, as regulated in the Foods Intended for Use in Energy Restricted Diets for Weight Reduction Regulations 1997 (SI 1997/2182), will be included in the obesity guidance currently under review by the National Institute for Health and Clinical Excellence; and

Whether they have examined the comparative costs of effective weight-management systems including commercial diets; and, if so, whether the results have been taken into account in developing guidelines for healthcare professionals.

Whether they have examined the comparative costs of effective weight-management systems including commercial diets; and, if so, whether the results have been taken into account in developing guidelines for healthcare professionals.

What assessment they are undertaking of the availability of vaccines against the causes of cervical cancer; which body is conducting such work; and to what timeframe.

What assessment they are undertaking of the availability of vaccines against the causes of cervical cancer; which body is conducting such work; and to what timeframe.

What is their latest estimate of the level of inappropriate pathology testing and its annual cost to the National Health Service.

What is their latest estimate of the level of inappropriate pathology testing and its annual cost to the National Health Service.

How many primary care trusts have adopted Payment by Results in 2006-07; how many primary care trusts they expect to (a) continue adopting Payment by Results, and (b) begin to adopt Payment by Results in 2007-08; and what monitoring they will conduct to ensure that the objectives of Payment by...

How many primary care trusts have adopted Payment by Results in 2006-07; how many primary care trusts they expect to (a) continue adopting Payment by Results, and (b) begin to adopt Payment by Results in 2007-08; and what monitoring they will conduct to ensure that the objectives of Payment by...

What assessment has been made of the effects of maintaining block contracts in the National Health Service.

What assessment has been made of the effects of maintaining block contracts in the National Health Service.

Whether block contracts will be allowed in the National Health Service (NHS) after Payment by Results has been implemented in 2008-09; what support and guidance will be provided to those NHS Trusts which maintain block contracts; and how NHS providers will be scrutinised to ensure that the system is being...

Whether block contracts will be allowed in the National Health Service (NHS) after Payment by Results has been implemented in 2008-09; what support and guidance will be provided to those NHS Trusts which maintain block contracts; and how NHS providers will be scrutinised to ensure that the system is being...

Whether manufacturers of products registered under the Traditional Herbal Medicinal Products Directive will be able to indicate on the label whether the products comply with organic standards of production; and, if not, what steps they will take to ensure that consumers of products registered under the directive are able to...

Whether manufacturers of products registered under the Traditional Herbal Medicinal Products Directive will be able to indicate on the label whether the products comply with organic standards of production; and, if not, what steps they will take to ensure that consumers of products registered under the directive are able to...

Whether they will issue commissioning guidance to ensure that existing levels of investment in adult audiology services are maintained while primary care trusts await the separate action plan promised by the Department of Health.

Whether they will issue commissioning guidance to ensure that existing levels of investment in adult audiology services are maintained while primary care trusts await the separate action plan promised by the Department of Health.

What sources of advice and information they provide on how primary care trusts and health authorities should make funding decisions for licensed pharmaceutical treatments or technologies which have not been considered by the National Institute for Health and Clinical Excellence.

What sources of advice and information they provide on how primary care trusts and health authorities should make funding decisions for licensed pharmaceutical treatments or technologies which have not been considered by the National Institute for Health and Clinical Excellence.

Whether they are planning to revise the Health Service Circular HSC/1999/176; if so, when a revised circular will be issued; and whether it will include new guidance for strategic health authorities and primary care trusts regarding the funding of licensed treatments or new technologies that have not been considered by...

Whether they are planning to revise the Health Service Circular HSC/1999/176; if so, when a revised circular will be issued; and whether it will include new guidance for strategic health authorities and primary care trusts regarding the funding of licensed treatments or new technologies that have not been considered by...

Further to the Written Answer by the Lord Warner on 6 March (WA 115), when the negotiations between NHS Employers and the British Medical Association's General Practitioners Committee for the general medical services contract for 2007–08 onwards will commence; and whether, as in the case of the general medical services...

Further to the Written Answer by the Lord Warner on 6 March (WA 115), when the negotiations between NHS Employers and the British Medical Association's General Practitioners Committee for the general medical services contract for 2007–08 onwards will commence; and whether, as in the case of the general medical services...